81237 Ezh2 gene common variants
Also known as: EZH2 common variant panel, EZH2 mutation testing
Molecular analysis of the EZH2 gene to identify common mutations associated with B-cell lymphomas.
In Plain Language
lymphoma gene test; blood cancer mutation screening
Clinical Context
Used to detect EZH2 mutations in lymphomas for prognostic assessment and prediction of response to EZH2 inhibitor therapy.
RVU Information
CPT 81237 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81237?
CPT 81237 (Ezh2 gene common variants) is a Pathology & Lab code. Molecular analysis of the EZH2 gene to identify common mutations associated with B-cell lymphomas.
Who uses CPT code 81237?
CPT 81237 is used by Hematology, Oncology, Pathology. Used to detect EZH2 mutations in lymphomas for prognostic assessment and prediction of response to EZH2 inhibitor therapy.
When is CPT 81237 used?
Used to detect EZH2 mutations in lymphomas for prognostic assessment and prediction of response to EZH2 inhibitor therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.